Related Experiment Videos
Synergistic anticryptosporidial potential of the combination alpha-1-antitrypsin and paromomycin
J R Forney1, S Yang, M C Healey
1Department of Biology, College of Science, Utah State University, Logan 84322-5600, USA.
Abstract:
The combined effect of the serine protease inhibitor alpha-1-antitrypsin (AAT) and the aminoglycoside paromomycin on Cryptosporidium parvum infection in vitro was investigated. AAT and paromomycin were mixed with C. parvum oocysts as either single or combined treatments and used to inoculate epithelial cell cultures. Single- and combined-treatment groups had significantly lower (P < 0.01) parasite numbers than untreated controls. The mean fractional inhibitory concentration indices suggested significant synergistic activity.
Insights
Alpha-1-antitrypsin (AAT) and paromomycin showed synergistic effects against Cryptosporidium parvum in vitro. Combined treatment significantly reduced parasite numbers in epithelial cell cultures.
Area of Science:
- Parasitology
- Infectious Diseases
- Pharmacology
Background:
- Cryptosporidium parvum is an opportunistic protozoan parasite causing significant gastrointestinal illness.
- Effective treatments for cryptosporidiosis remain limited, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the in vitro efficacy of alpha-1-antitrypsin (AAT) and paromomycin, alone and in combination, against Cryptosporidium parvum.
Main Methods:
- Cryptosporidium parvum oocysts were treated with AAT and/or paromomycin.
- Treated oocysts were used to inoculate epithelial cell cultures.
- Parasite burden was quantified and analyzed for synergistic effects.
Main Results:
- Both single and combined treatments significantly reduced parasite numbers compared to untreated controls (P < 0.01).
- Fractional inhibitory concentration indices indicated significant synergistic activity between AAT and paromomycin.
Conclusions:
- AAT and paromomycin exhibit synergistic activity against Cryptosporidium parvum in vitro.
- This combination therapy holds potential for treating cryptosporidiosis.